Last reviewed · How we verify
Barbotage
At a glance
| Generic name | Barbotage |
|---|---|
| Sponsor | NYU Langone Health |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Calciying Tendinopathy of the Rotator Cuff: Barbotage Vs Shock Waves (NA)
- Endoscopic Submucosal Dissection of Large Recto-sigmoid Lesions Under Spinal Anesthesia
- Calcific Tendonitis Treatment: Barbotage vs. Barbotage With Cortisone Injection (PHASE4)
- Treatment of Calcific Tendinitis of the Rotator Cuff (NA)
- Spinal Analgesia as Fast Track Painless Labor
- Comparison of the Efficiency of Ultrasound-Guided Lavage and Subacromial Bursa Injection in Calcific Tendinitis (NA)
- Comparison of Focused Shock Waves or Ultrasound-Guided Needling and Lavage in Patients With Calcifying Tendinopathy of the Shoulder (NA)
- Comparison of Intrathecal Dexmedetomidine Versus Fentanyl as Adjuvants to Bupivacaine on Post-operative Urinary Retention in Knee Joint Arthroscopic Surgeries (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Barbotage CI brief — competitive landscape report
- Barbotage updates RSS · CI watch RSS
- NYU Langone Health portfolio CI